Enzastaurin cardiotoxicity: QT interval prolongation, negative inotropic responses and negative chronotropic action.
Enzastaurin cardiotoxicity: QT interval prolongation, negative inotropic responses and negative chronotropic action.
复制标题
Enzastaurin 心脏毒性:QT 间期延长、负性肌力反应和负性变时作用。
DOI:
10.1016/j.bcp.2023.115443
复制
发表时间:
2023
影响因子:
5.8
通讯作者:
Yanhui Zhang
中科院分区:
文献类型:
--
作者:
Heng Zhang;Jianghua Lin;Lei Pan;Liang Mao;Jingtuan Pang;Qian;Gui;Gang;Yang Lin;Bao;Yun;Yan Wang;Ling Jie;Yanhui Zhang
Several clinical trials observed that enzastaurin prolonged QT interval in cancer patients. However, the mechanism of enzastaurin-induced QT interval prolongation is unclear. Therefore, this study aimed to assess the effect and mechanism of enzastaurin on QT interval and cardiac function. The Langendorff and Ion-Optix MyoCam systems were used to assess the effects of enzastaurin on QT interval, cardiac systolic function and intracellular Ca2+transient in guinea pig hearts and ventricular myocytes. The effects of enzastaurin on the rapid delayed rectifier (IKr), the slow delayed rectifier K+current (IKs), transient outward potassium current (Ito), action potentials, Ryanodine Receptor 2 (RyR2) and the sarcoplasmic/endoplasmic reticulum Ca2+ATPase 2a (SERCA2a) expression and activity in HEK 293 cell system and primary cardiomyocytes were investigated using whole-cell recording technique and western blotting. We found that enzastaurin significantly prolonged QT interval in guinea pig hearts and increased the action potential duration (APD) in guinea pig cardiomyocytes in a dose-dependent manner. Enzastaurin potently inhibitedIKrby binding to the human Ether-à-go-go-Related gene (hERG) channel in both open and closed states, and hERG mutant channels, including S636A, S631A, and F656V attenuated the inhibitory effect of enzastaurin. Enzastaurin also moderately decreasedIKs. Additionally, enzastaurin also induced negative chronotropic action. Moreover, enzastaurin impaired cardiac systolic function and reduced intracellular Ca2+transient via inhibition of RyR2 phosphorylation. Taken together, we found that enzastaurin prolongs QT, reduces heart rate and impairs cardiac systolic function. Therefore, we recommend that electrocardiogram (ECG) and cardiac function should be continuously monitored when enzastaurin is administered to cancer patients.
登录
查看更多内容
影响因子:
64.5
作者:
Wang W;MacKinnon R
通讯作者:
MacKinnon R
DOI:
--
发表时间:
1994-04
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
M. Slawsky;N. Castle
通讯作者:
M. Slawsky;N. Castle
影响因子:
15.9
作者:
Kilburn,LindsayB;Kocak,Mehmet;Decker,RodneyL;Wetmore,Cynthia;Chintagumpala,Murali;Su,Jack;Goldman,Stewart;Banerjee,Anuradha;Gilbertson,Richard;Fouladi,Maryam;Kun,Larry;Boyett,JamesM;Blaney,SusanM
通讯作者:
Blaney,SusanM
DOI:
10.1006/jmcc.1998.0834
发表时间:
1998
期刊:
Journal of molecular and cellular cardiology.
影响因子:
--
作者:
Yao,A;Su,Z;Dillmann,WH;Barry,WH
通讯作者:
Barry,WH
影响因子:
3.6
作者:
Kamiya, K;Mitcheson, JS;Sanguinetti, MC
通讯作者:
Sanguinetti, MC